A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Healthy Adults
Interventions
DRUG

CoFactor

DRUG

Leucovorin

Trial Locations (1)

21225

Parexel International - Baltimore CPRU, Baltimore

Sponsors
All Listed Sponsors
lead

Mast Therapeutics, Inc.

INDUSTRY

NCT00663481 - A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects. | Biotech Hunter | Biotech Hunter